Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Visual feedback explains why propointing is better than antipointing in spatial neglect.

Utz KS, Hesse C, Hintz A, Grüneberger D, Kulke H, Roth I, Klos T, Kromichal V, Melms A, Schupp W, Kohl D, Schenk T.

Cortex. 2018 Jan;98:114-127. doi: 10.1016/j.cortex.2017.05.012. Epub 2017 May 25.

PMID:
28648411
2.

Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?

Lee DH, Seubert S, Huhn K, Brecht L, Rötger C, Waschbisch A, Schlachetzki J, Klausmeyer A, Melms A, Wiese S, Winkler J, Linker RA.

PLoS One. 2017 Mar 8;12(3):e0171552. doi: 10.1371/journal.pone.0171552. eCollection 2017.

3.

International consensus guidance for management of myasthenia gravis: Executive summary.

Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P.

Neurology. 2016 Jul 26;87(4):419-25. doi: 10.1212/WNL.0000000000002790. Epub 2016 Jun 29. Review.

4.

Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology.

Sunderkötter C, Nast A, Worm M, Dengler R, Dörner T, Ganter H, Hohlfeld R, Melms A, Melzer N, Rösler K, Schmidt J, Sinnreich M, Walter MC, Wanschitz J, Wiendl H.

J Dtsch Dermatol Ges. 2016 Mar;14(3):321-38. doi: 10.1111/ddg.12909.

PMID:
26972210
5.

Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, Melms A, Tackenberg B, Schalke B, Schneider-Gold C, Zimprich F, Meuth SG, Wiendl H.

J Neurol. 2016 Aug;263(8):1473-94. doi: 10.1007/s00415-016-8045-z. Epub 2016 Feb 17. Review.

6.

Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System.

Waschbisch A, Schröder S, Schraudner D, Sammet L, Weksler B, Melms A, Pfeifenbring S, Stadelmann C, Schwab S, Linker RA.

J Immunol. 2016 Feb 15;196(4):1558-67. doi: 10.4049/jimmunol.1501960. Epub 2016 Jan 8.

7.

Genome-wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A, and Identification of ZBTB10 and Three Distinct HLA Associations.

Seldin MF, Alkhairy OK, Lee AT, Lamb JA, Sussman J, Pirskanen-Matell R, Piehl F, Verschuuren JJ, Kostera-Pruszczyk A, Szczudlik P, Mckee D, Maniaol AH, Harbo HF, Lie BA, Melms A, Garchon HJ, Willcox N, Gregersen PK, Hammarstrom L.

Mol Med. 2015 Oct 10. doi: 10.2119/molmed.2015.00232. [Epub ahead of print]

8.

Role of glial 14-3-3 gamma protein in autoimmune demyelination.

Lee DH, Steinacker P, Seubert S, Turnescu T, Melms A, Manzel A, Otto M, Linker RA.

J Neuroinflammation. 2015 Oct 6;12:187. doi: 10.1186/s12974-015-0381-x.

9.

VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis.

Avidan N, Le Panse R, Harbo HF, Bernasconi P, Poulas K, Ginzburg E, Cavalcante P, Colleoni L, Baggi F, Antozzi C, Truffault F, Horn-Saban S, Pöschel S, Zagoriti Z, Maniaol A, Lie BA, Bernard I, Saoudi A, Illes Z, Casasnovas Pons C, Melms A, Tzartos S, Willcox N, Kostera-Pruszczyk A, Tallaksen C, Mantegazza R, Berrih-Aknin S, Miller A.

Ann Clin Transl Neurol. 2014 May;1(5):329-39. doi: 10.1002/acn3.51. Epub 2014 Apr 11.

10.

Anti-agrin autoantibodies in myasthenia gravis.

Gasperi C, Melms A, Schoser B, Zhang Y, Meltoranta J, Risson V, Schaeffer L, Schalke B, Kröger S.

Neurology. 2014 Jun 3;82(22):1976-83. doi: 10.1212/WNL.0000000000000478. Epub 2014 May 2.

PMID:
24793185
11.

New poteintial serum biomarkers in multiple sclerosis identified by proteomic strategies.

Amin B, Maurer A, Voelter W, Melms A, Kalbacher H.

Curr Med Chem. 2014;21(13):1544-56.

PMID:
24180278
12.

Isolation of myeloid dendritic cells and epithelial cells from human thymus.

Stoeckle C, Rota IA, Tolosa E, Haller C, Melms A, Adamopoulou E.

J Vis Exp. 2013 Sep 19;(79):e50951. doi: 10.3791/50951.

13.

Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells.

Klose J, Schmidt NO, Melms A, Dohi M, Miyazaki J, Bischof F, Greve B.

J Neuroinflammation. 2013 Sep 22;10:117. doi: 10.1186/1742-2094-10-117.

14.

Exploring the MHC-peptide matrix of central tolerance in the human thymus.

Adamopoulou E, Tenzer S, Hillen N, Klug P, Rota IA, Tietz S, Gebhardt M, Stevanovic S, Schild H, Tolosa E, Melms A, Stoeckle C.

Nat Commun. 2013;4:2039. doi: 10.1038/ncomms3039.

15.

The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.

Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Ströbel P.

Autoimmun Rev. 2013 Jul;12(9):875-84. doi: 10.1016/j.autrev.2013.03.007. Epub 2013 Mar 25. Review.

PMID:
23535159
16.

Plasma exchange is effective in a 13-year-old girl with steroid-resistant bilateral optic neuritis.

Michaelis I, Bender B, Beringer O, Melms A, Krägeloh-Mann I, Wolff M.

Neuropediatrics. 2013 Oct;44(5):272-5. doi: 10.1055/s-0033-1336018. Epub 2013 Mar 6.

PMID:
23468279
17.

Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy.

Neidert MC, Schoor O, Trautwein C, Trautwein N, Christ L, Melms A, Honegger J, Rammensee HG, Herold-Mende C, Dietrich PY, Stevanović S.

J Neurooncol. 2013 Feb;111(3):285-94. doi: 10.1007/s11060-012-1028-8. Epub 2012 Dec 23.

PMID:
23263746
18.

Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke.

Wurster T, Poetz O, Stellos K, Kremmer E, Melms A, Schuster A, Nagel E, Joos T, Gawaz M, Bigalke B.

Platelets. 2013;24(7):560-5. doi: 10.3109/09537104.2012.746455. Epub 2012 Dec 5.

PMID:
23215725
19.

Visual impairment in stroke patients--a review.

Sand KM, Midelfart A, Thomassen L, Melms A, Wilhelm H, Hoff JM.

Acta Neurol Scand Suppl. 2013;(196):52-6. doi: 10.1111/ane.12050. Review.

PMID:
23190292
20.

Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.

Müller S, Saur R, Greve B, Melms A, Hautzinger M, Fallgatter AJ, Leyhe T.

Mult Scler. 2013 May;19(6):799-805. doi: 10.1177/1352458512461392. Epub 2012 Nov 19.

PMID:
23166118
21.

Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.

Maetzler W, Tian Y, Baur SM, Gauger T, Odoj B, Schmid B, Schulte C, Deuschle C, Heck S, Apel A, Melms A, Gasser T, Berg D.

PLoS One. 2012;7(10):e48042. doi: 10.1371/journal.pone.0048042. Epub 2012 Oct 25.

22.

Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.

Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, McKee D, Simpfendorfer KR, Pirskanen-Matell R, Piehl F, Pan-Hammarstrom Q, Verschuuren JJ, Titulaer MJ, Niks EH, Marx A, Ströbel P, Tackenberg B, Pütz M, Maniaol A, Elsais A, Tallaksen C, Harbo HF, Lie BA, Raychaudhuri S, de Bakker PI, Melms A, Garchon HJ, Willcox N, Hammarstrom L, Seldin MF.

Ann Neurol. 2012 Dec;72(6):927-35. doi: 10.1002/ana.23691. Epub 2012 Oct 10.

23.

[Behçet's disease].

Kötter I, Xenitidis T, Fierlbeck G, Schanz S, Melms A, Horger M, Ernemann U, Deuter C.

Z Rheumatol. 2012 Oct;71(8):685-96; quiz 697. doi: 10.1007/s00393-012-1012-x. German.

PMID:
23052559
24.

[Neurological manifestations of vasculitis and primary central nervous system vasculitis].

Magnus T, Melms A, Kötter I, Holle JU.

Z Rheumatol. 2012 Sep;71(7):551-63. doi: 10.1007/s00393-012-0957-0. German.

PMID:
22930106
25.

[Neurology and rheumatology].

Kötter I, Melms A.

Z Rheumatol. 2012 Sep;71(7):550. doi: 10.1007/s00393-012-0956-1. German. No abstract available.

PMID:
22930105
26.

Current concepts of the interventional treatment of proximal supraaortic vessel stenosis.

Ernemann U, Bender B, Melms A, Brechtel K, Kobba J, Balletshofer B.

Vasa. 2012 Sep;41(5):313-8. doi: 10.1024/0301-1526/a000216. Review.

PMID:
22915528
27.

Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke.

Doehner W, von Haehling S, Suhr J, Ebner N, Schuster A, Nagel E, Melms A, Wurster T, Stellos K, Gawaz M, Bigalke B.

J Am Coll Cardiol. 2012 Jul 24;60(4):346-54. doi: 10.1016/j.jacc.2012.04.024.

28.

[Extraocular manifestations of Behcet's disease].

Kötter I, Xenitidis T, Fierlbeck G, Schanz S, Melms A, Horger M, Ernemann U, Deuter C.

Ophthalmologe. 2012 Jun;109(6):548-57. doi: 10.1007/s00347-011-2502-y. German.

PMID:
22699945
29.

Similar autobiographical memory impairment in long-term secondary progressive multiple sclerosis and Alzheimer's disease.

Müller S, Saur R, Greve B, Melms A, Hautzinger M, Fallgatter AJ, Leyhe T.

Mult Scler. 2013 Feb;19(2):225-32. doi: 10.1177/1352458512450352. Epub 2012 Jun 8.

PMID:
22685064
30.

Early sign of hemodynamic insufficiency in the MCA watershed territories: Just the (finger)tip of the iceberg?

Zizlsperger L, Ernemann U, Erharhaghen J, Melms A, Haarmeier T.

Neurol Clin Pract. 2012 Jun;2(2):162-164. doi: 10.1212/CPJ.0b013e31825a6197. No abstract available.

31.

Cathepsin S dominates autoantigen processing in human thymic dendritic cells.

Stoeckle C, Quecke P, Rückrich T, Burster T, Reich M, Weber E, Kalbacher H, Driessen C, Melms A, Tolosa E.

J Autoimmun. 2012 Jun;38(4):332-43. doi: 10.1016/j.jaut.2012.02.003. Epub 2012 Mar 16.

PMID:
22424724
32.

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Bergh FT, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Münch C, Winkelmann A, Zettl U UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F.

J Neuroinflammation. 2012 Jan 19;9:14. doi: 10.1186/1742-2094-9-14.

33.

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.

Jarius S, Paul F, Franciotta D, de Seze J, Münch C, Salvetti M, Ruprecht K, Liebetrau M, Wandinger KP, Akman-Demir G, Melms A, Kristoferitsch W, Wildemann B.

Mult Scler. 2012 Aug;18(8):1135-43. doi: 10.1177/1352458511431728. Epub 2011 Dec 19. Review.

PMID:
22183934
34.

Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma.

Schittenhelm J, Mittelbronn M, Meyermann R, Melms A, Tatagiba M, Capper D.

Acta Neuropathol. 2011 Nov;122(5):651-2. doi: 10.1007/s00401-011-0885-0. Epub 2011 Oct 8. No abstract available.

PMID:
21983902
35.

Expression of stromal-cell-derived factor-1 (SDF-1): a predictor of ischaemic stroke?

Wurster T, Stellos K, Geisler T, Seizer P, Andia ME, Schuster A, May AE, Melms A, Gawaz M, Bigalke B.

Eur J Neurol. 2012 Mar;19(3):395-401. doi: 10.1111/j.1468-1331.2011.03527.x. Epub 2011 Sep 26.

PMID:
21951424
36.

An unusual location of deep venous thrombosis associated with ischemic stroke and persistent foramen ovale.

Erharhaghen J, Bartz M, Di Giovanni S, Melms A, Haarmeier T, Sieverding L.

Case Rep Neurol. 2011 May;3(2):160-4. doi: 10.1159/000330376. Epub 2011 Jul 19.

37.

Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.

Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A, Kröger S.

J Neurol. 2012 Mar;259(3):427-35. doi: 10.1007/s00415-011-6194-7. Epub 2011 Aug 5.

PMID:
21814823
38.

Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.

Maetzler W, Stapf AK, Schulte C, Hauser AK, Lerche S, Wurster I, Schleicher E, Melms A, Berg D.

J Alzheimers Dis. 2011;27(1):119-26. doi: 10.3233/JAD-2011-110587.

PMID:
21765209
39.

Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.

Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A, Gasser T, Hörnig S, Langkamp M.

J Alzheimers Dis. 2011;26(1):171-9. doi: 10.3233/JAD-2011-110221.

PMID:
21593566
40.

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.

Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B.

J Neurol Sci. 2011 Jul 15;306(1-2):82-90. doi: 10.1016/j.jns.2011.03.038. Epub 2011 May 6.

PMID:
21550068
41.

Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.

Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D, Rommer P, Mader S, Kleiter I, Reindl M, Akman-Demir G, Seifert-Held T, Kristoferitsch W, Melms A, Wandinger KP, Wildemann B.

Mult Scler. 2011 Sep;17(9):1067-73. doi: 10.1177/1352458511403958. Epub 2011 May 4.

PMID:
21543553
42.

A novel clinical syndrome revealing a deficiency of the muscarinic M3 receptor.

Pomper JK, Wilhelm H, Tayebati SK, Asmus F, Schüle R, Sievert KD, Haensch CA, Melms A, Haarmeier T.

Neurology. 2011 Feb 1;76(5):451-5. doi: 10.1212/WNL.0b013e31820a0a75.

PMID:
21282591
43.

[Time is brain: not only in stroke].

Bux C, Erharhaghen J, Bisdas S, Schlak D, Melms A, Haarmeier T.

Nervenarzt. 2011 Aug;82(8):1038-9. doi: 10.1007/s00115-010-3212-4. German. No abstract available.

PMID:
21206995
44.

Cerebral low-grade lymphoma and light chain deposition disease: exceedingly high IgG levels in the cerebrospinal fluid as a diagnostic clue.

Pantazis G, Psaras T, Krope K, von Coelln R, Fend F, Bock T, Schittenhelm J, Melms A, Meyermann R, Bornemann A.

Clin Neuropathol. 2010 Nov-Dec;29(6):378-83.

45.

Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.

Maetzler W, Stoycheva V, Schmid B, Schulte C, Hauser AK, Brockmann K, Melms A, Gasser T, Berg D.

J Alzheimers Dis. 2010;22(3):933-8. doi: 10.3233/JAD-2010-101197.

PMID:
20858953
46.

CD62L(high) Treg cells with superior immunosuppressive properties accumulate within the CNS during remissions of EAE.

Lange C, Scholl M, Melms A, Bischof F.

Brain Behav Immun. 2011 Jan;25(1):120-6. doi: 10.1016/j.bbi.2010.09.004. Epub 2010 Sep 15.

PMID:
20837133
47.

Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses.

Sellner J, Cepok S, Kalluri SR, Nestler A, Kleiter I, Kümpfel T, Linker R, Melms A, Menge T, Tumani H, Paul F, Hemmer B, Berthele A.

Neurochem Int. 2010 Nov;57(6):662-7. doi: 10.1016/j.neuint.2010.08.003. Epub 2010 Aug 10.

PMID:
20705110
48.

Guidelines for treatment of autoimmune neuromuscular transmission disorders.

Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW; European Federation of Neurological Societies.

Eur J Neurol. 2010 Jul;17(7):893-902. doi: 10.1111/j.1468-1331.2010.03019.x. Epub 2010 Apr 12.

PMID:
20402760
49.

The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease.

Maetzler W, Schmid B, Synofzik M, Schulte C, Riester K, Huber H, Brockmann K, Gasser T, Berg D, Melms A.

J Alzheimers Dis. 2010;19(3):937-42. doi: 10.3233/JAD-2010-1289.

PMID:
20157249
50.

Expression of platelet glycoprotein VI is associated with transient ischemic attack and stroke.

Bigalke B, Stellos K, Geisler T, Kremmer E, Seizer P, May AE, Lindemann S, Melms A, Luft A, Gawaz M.

Eur J Neurol. 2010 Jan;17(1):111-7. doi: 10.1111/j.1468-1331.2009.02754.x. Epub 2009 Jul 21.

Supplemental Content

Support Center